Review paper
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis
Abstract
Autoimmune hepatitis (AIH) is a rare disease of unclear etiology characterized by loss of self-tolerance that can lead to liver injury, cirrhosis, and acute liver failure. First-line treatment consists of systemic corticosteroids, or budesonide, and azathioprine, to which most patients are initially responsive, although predictors of response are lacking. Relapses are very common, correlate with histological activity despite normal serum...
Paper Details
Title
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis
Published Date
May 25, 2022
Journal
Volume
76
Issue
6
Pages
1862 - 1879